The University of Chicago Header Logo

Connection

Elbert Huang to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Elbert Huang has written about Cost-Benefit Analysis.
Elbert Huang
Connection Strength
2.306
Cost-Benefit Analysis
  1. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
    View in: PubMed
    Score: 0.345
  2. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Aliment Pharmacol Ther. 2007 Oct 15; 26(8):1147-61.
    View in: PubMed
    Score: 0.229
  3. The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes. Appl Health Econ Health Policy. 2024 Nov; 22(6):861-869.
    View in: PubMed
    Score: 0.185
  4. The Economic Evaluation of Team Clinic-Group Approach to a Care Model of Early Adolescents With Type 1 Diabetes. J Pediatr Health Care. 2022 Sep-Oct; 36(5):430-437.
    View in: PubMed
    Score: 0.159
  5. Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 08; 162(2):249-255.
    View in: PubMed
    Score: 0.147
  6. Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial. Diabetes Care. 2019 08; 42(8):1589-1592.
    View in: PubMed
    Score: 0.128
  7. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making. 2018 11; 38(8):942-953.
    View in: PubMed
    Score: 0.123
  8. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018 06; 41(6):1227-1234.
    View in: PubMed
    Score: 0.118
  9. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
    View in: PubMed
    Score: 0.116
  10. The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar; 34(3):622-7.
    View in: PubMed
    Score: 0.072
  11. The public health implications of the cost-effectiveness of bariatric surgery for diabetes. Diabetes Care. 2010 Sep; 33(9):2126-8.
    View in: PubMed
    Score: 0.070
  12. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2010 Jun; 33(6):1269-74.
    View in: PubMed
    Score: 0.068
  13. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008 Aug; 10(4):310-21.
    View in: PubMed
    Score: 0.061
  14. The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res. 2007 Dec; 42(6 Pt 1):2174-93; discussion 2294-323.
    View in: PubMed
    Score: 0.058
  15. Estimating costs of quality improvement for outpatient healthcare organisations: a practical methodology. Qual Saf Health Care. 2007 Aug; 16(4):248-51.
    View in: PubMed
    Score: 0.056
  16. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006 Feb; 29(2):259-64.
    View in: PubMed
    Score: 0.051
  17. Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity. JAMA Health Forum. 2025 Apr 04; 6(4):e250905.
    View in: PubMed
    Score: 0.048
  18. Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. JAMA Health Forum. 2025 Mar 07; 6(3):e245586.
    View in: PubMed
    Score: 0.048
  19. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
    View in: PubMed
    Score: 0.040
  20. Cost and healthcare utilization analysis of culturally sensitive, shared medical appointment model for Latino children with type 1 diabetes. Pediatr Diabetes. 2021 08; 22(5):816-822.
    View in: PubMed
    Score: 0.037
  21. Health economic analyses of the justice community opioid innovation network (JCOIN). J Subst Abuse Treat. 2021 09; 128:108262.
    View in: PubMed
    Score: 0.036
  22. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. Am J Gastroenterol. 2021 01 01; 116(1):125-133.
    View in: PubMed
    Score: 0.036
  23. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019 12; 42(12):2247-2255.
    View in: PubMed
    Score: 0.033
  24. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.024
  25. Health utilities for children and adults with type 1 diabetes. Med Care. 2011 Oct; 49(10):924-31.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.